- Home
- VIR vs CINT Comparison
VIR vs CINT Comparison
Compare VIR & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- CINT
- Stock Information
- Founded
- VIR 2016
- CINT 1995
- Country
- VIR United States
- CINT Brazil
- Employees
- VIR N/A
- CINT N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- CINT EDP Services
- Sector
- VIR Health Care
- CINT Technology
- Exchange
- VIR Nasdaq
- CINT Nasdaq
- Market Cap
- VIR 706.4M
- CINT 803.4M
- IPO Year
- VIR 2019
- CINT 2021
- Fundamental
- Price
- VIR $5.65
- CINT $5.70
- Analyst Decision
- VIR Strong Buy
- CINT Buy
- Analyst Count
- VIR 8
- CINT 7
- Target Price
- VIR $30.25
- CINT $7.61
- AVG Volume (30 Days)
- VIR 1.2M
- CINT 92.5K
- Earning Date
- VIR 07-31-2025
- CINT 08-15-2025
- Dividend Yield
- VIR N/A
- CINT N/A
- EPS Growth
- VIR N/A
- CINT 53.80
- EPS
- VIR N/A
- CINT 0.24
- Revenue
- VIR $20,861,000.00
- CINT $444,135,000.00
- Revenue This Year
- VIR N/A
- CINT $526.02
- Revenue Next Year
- VIR $0.62
- CINT $12.77
- P/E Ratio
- VIR N/A
- CINT $23.81
- Revenue Growth
- VIR N/A
- CINT 3.04
- 52 Week Low
- VIR $4.32
- CINT $4.42
- 52 Week High
- VIR $14.45
- CINT $8.04
- Technical
- Relative Strength Index (RSI)
- VIR 57.21
- CINT 43.28
- Support Level
- VIR $5.20
- CINT $5.89
- Resistance Level
- VIR $6.23
- CINT $5.94
- Average True Range (ATR)
- VIR 0.30
- CINT 0.16
- MACD
- VIR 0.07
- CINT -0.01
- Stochastic Oscillator
- VIR 56.06
- CINT 4.65
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About CINT CI&T Inc
CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.